Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radiation and platinum drug interaction.

A H Nias

    International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine
    |September 1, 1985
    PubMed
    Summary

    Platinum drugs interact with radiation therapy by inhibiting cell recovery and causing DNA damage, potentially enhancing tumor response. Optimal drug-radiation timing and dosage are crucial for maximizing benefits while minimizing toxicity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Get some research under your belt.

    Journal of the Royal Society of Medicine·1996
    Same author

    Effect of azelaic acid on melanoma cells in culture.

    Experimental dermatology·1995
    Same author

    The effect of paraquat on the radiosensitivity of melanoma cells: the role of superoxide dismutase & catalase.

    Free radical research communications·1993
    Same author

    The optimum pressure of oxygen for radiotherapy of a mouse tumour.

    The British journal of radiology·1992
    Same author

    Rate of metastasis from C3H mouse mammary tumours.

    Clinical & experimental metastasis·1992
    Same author

    Nitrous oxide--radiosensitizer or radioprotector?

    The British journal of radiology·1991

    Area of Science:

    • Oncology
    • Radiation Oncology
    • Pharmacology

    Background:

    • Platinum-based chemotherapy agents possess complex chemical, biochemical, and biological effects.
    • These effects can significantly interact with the mechanisms of radiation therapy.
    • Platinum drugs are known to inhibit cellular recovery from radiation-induced damage.

    Purpose of the Study:

    • To explore the multifaceted interactions between platinum drugs and radiation therapy.
    • To understand how platinum drugs affect cellular responses to radiation, including DNA damage and recovery.
    • To evaluate the potential for platinum drugs to radiosensitize tumor cells, particularly hypoxic cells.

    Main Methods:

    • Analysis of platinum drug effects on cellular recovery from radiation damage.
    • Investigation of platinum drug-induced chromosome aberrations.
    • Assessment of cellular sensitivity to platinum drugs in relation to glutathione levels and cell cycle phase.
    • Evaluation of the radiosensitizing potential of platinum drugs, considering their electron-affinity and DNA-targeting properties.

    Main Results:

    • Platinum drugs inhibit recovery from sublethal and potentially lethal radiation damage.
    • They induce chromosome aberrations similar to alkylating agents.
    • Cellular sensitivity to platinum drugs is influenced by glutathione levels and cell cycle phase, with distinct patterns from radiosensitivity.
    • Platinum drugs exhibit a quasi-alkylating action, contributing to radiosensitization through DNA targeting.

    Conclusions:

    • Platinum drugs can enhance radiation effects by inhibiting cellular repair mechanisms and directly targeting DNA.
    • The ideal platinum drug-radiation combination requires careful consideration of drug dosage, timing, and inherent drug properties to achieve tumor radiosensitization without excessive normal tissue toxicity.
    • Clinical outcomes, including tumor response and patient morbidity, are dependent on the specific platinum drug, dose, and administration-radiation interval.

    Related Experiment Videos